Decatur Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-78,233
| Closed | -$4.94M | – | 62 |
|
|
2020
Q3 | $4.94M | Buy |
78,233
+14,940
| +24% | +$944K | 0.97% | 44 |
|
|
2020
Q2 | $4.87M | Buy |
63,293
+12,601
| +25% | +$970K | 1.29% | 29 |
|
|
2020
Q1 | $3.79M | Sell |
50,692
-12,949
| -20% | -$968K | 1.27% | 32 |
|
|
2019
Q4 | $4.14M | Sell |
63,641
-37,949
| -37% | -$2.47M | 0.95% | 48 |
|
|
2019
Q3 | $6.44M | Sell |
101,590
-39,425
| -28% | -$2.5M | 1.59% | 20 |
|
|
2019
Q2 | $9.53M | Sell |
141,015
-3,251
| -2% | -$220K | 1.79% | 17 |
|
|
2019
Q1 | $9.38M | Buy |
144,266
+38,866
| +37% | +$2.53M | 1.81% | 16 |
|
|
2018
Q4 | $6.59M | Buy |
+105,400
| New | +$6.59M | 1.48% | 30 |
|
|
2014
Q4 | – | Sell |
-122,500
| Closed | -$13M | – | 100 |
|
|
2014
Q3 | $13M | Buy |
122,500
+24,275
| +25% | +$2.58M | 2.19% | 17 |
|
|
2014
Q2 | $8.14M | Sell |
98,225
-49,400
| -33% | -$4.1M | 1.54% | 25 |
|
|
2014
Q1 | $10.5M | Buy |
147,625
+50,175
| +51% | +$3.56M | 1.99% | 11 |
|
|
2013
Q4 | $7.32M | Buy |
+97,450
| New | +$7.32M | 1.41% | 26 |
|